Related Experiment Video
Updated: Mar 21, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Pulmonary Fungal Diseases in Immunocompetent Hosts: A Single-Center Retrospective Analysis of 35 Subjects
XiaoPei Yan1, Feng Zong2, Hui Kong3
1Department of Respirology, First People's Hospital of Changzhou, Changzhou, 213000, China.
Background:
Pulmonary fungal disease is an emerging issue in immunocompetent patients, for whom the characteristics are only partially understood.
Methods:
We conducted a single-center retrospective study of histologically verified pulmonary fungal disease in Eastern China from 2006 to 2014 to understand the demographics, clinical manifestations, therapeutic approaches, and factors associated with prognosis in this population. All cases were diagnosed according to the 2008 European Organization for the Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infection Diseases Mycoses Study Group definition criteria.
Results:
A total of 112 cases of pulmonary fungal diseases were enrolled (35 proven, 16 probable, 61 possible), and we analyzed the 35 patients with histologically proven pulmonary fungal diseases in this study. The main fungal species identified were Aspergillus (51.4 %), Cryptococcus (22.9 %), and Mucor (2.4 %). Treatment consisted of antifungal therapeutic agents (54.3 %), surgery and postsurgical agents (25.7 %), or surgery alone (14.3 %). The overall crude mortality rate was 14.3 %, and the mortality due to pulmonary fungal infections was 2.9 %. Significant predictors of mortality by univariate analysis were hypoalbuminemia (P = 0.005), cancer (P = 0.008), and positive culture (P = 0.044). Additionally, hypoalbuminemia was the only risk factor for mortality by multivariate analysis (RR = 7.56, 95 % CI 1.38-41.46).
Conclusion:
Pulmonary fungal disease in immunocompetent patients, with Aspergillus as the most common identified species, had a prognosis that was influenced by the level of serum albumin.
Insights
Pulmonary fungal disease is increasing in immunocompetent individuals. Low serum albumin levels significantly predict mortality in these patients, highlighting a key prognostic factor.
Area of Science:
- Medical Mycology
- Pulmonology
- Infectious Diseases
Background:
- Pulmonary fungal disease is an emerging concern in immunocompetent individuals.
- Characteristics of fungal lung infections in this population are not fully understood.
Purpose of the Study:
- To investigate the demographics, clinical features, treatments, and prognostic factors of pulmonary fungal disease in immunocompetent patients.
- To understand the epidemiological characteristics and outcomes of these infections in Eastern China.
Main Methods:
- Retrospective single-center study of histologically verified pulmonary fungal disease cases from 2006 to 2014.
- Diagnosis followed European Organization for the Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infection Diseases Mycoses Study Group criteria.
Main Results:
- Aspergillus (51.4%), Cryptococcus (22.9%), and Mucor (2.4%) were the most common fungal species identified.
- Treatments included antifungal agents (54.3%), surgery with postsurgical agents (25.7%), or surgery alone (14.3%).
- Hypoalbuminemia was identified as the sole significant risk factor for mortality (RR=7.56) in multivariate analysis.
Conclusions:
- Aspergillus is the predominant fungal species causing pulmonary disease in immunocompetent patients.
- Serum albumin levels are a critical factor influencing prognosis in these patients.
- Early identification and management of hypoalbuminemia may improve outcomes.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Phylum Microsporidia
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Other Pulmonary Disorders
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Ascomycota